Page last updated: 2024-10-27

fluorouracil and Bannayan-Riley-Ruvalcaba Syndrome

fluorouracil has been researched along with Bannayan-Riley-Ruvalcaba Syndrome in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Čeović, R1
Smolković, N1
Pašić, A1
Kostović, K1
Hrsan, D1

Other Studies

1 other study available for fluorouracil and Bannayan-Riley-Ruvalcaba Syndrome

ArticleYear
Multiple basal cell carcinomas of lower legs with stasis dermatitis: a therapeutic challenge.
    Acta dermatovenerologica Croatica : ADC, 2012, Volume: 20, Issue:3

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Hamartoma S

2012